Stansberry Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.54M | Buy |
94,778
+87
| +0.1% | +$6.01K | 0.71% | 55 |
|
|
2025
Q1 | $6.58M | Buy |
94,691
+8,090
| +9% | +$562K | 0.79% | 48 |
|
|
2024
Q4 | $7.45M | Buy |
86,601
+24,178
| +39% | +$2.08M | 0.97% | 43 |
|
|
2024
Q3 | $7.43M | Buy |
62,423
+3,142
| +5% | +$374K | 0.93% | 43 |
|
|
2024
Q2 | $8.46M | Buy |
59,281
+7,219
| +14% | +$1.03M | 1.11% | 33 |
|
|
2024
Q1 | $6.68M | Buy |
52,062
+8,733
| +20% | +$1.12M | 0.9% | 41 |
|
|
2023
Q4 | $4.48M | Sell |
43,329
-3,571
| -8% | -$369K | 0.74% | 43 |
|
|
2023
Q3 | $4.27M | Buy |
46,900
+502
| +1% | +$45.7K | 0.75% | 46 |
|
|
2023
Q2 | $3.75M | Buy |
46,398
+2,518
| +6% | +$204K | 0.69% | 45 |
|
|
2023
Q1 | $3.49M | Buy |
43,880
+19,558
| +80% | +$1.56M | 0.68% | 46 |
|
|
2022
Q4 | $1.65M | Buy |
24,322
+4,382
| +22% | +$297K | 0.34% | 56 |
|
|
2022
Q3 | $994K | Buy |
19,940
+1,644
| +9% | +$82K | 0.21% | 69 |
|
|
2022
Q2 | $1.02M | Sell |
18,296
-558
| -3% | -$31.1K | 0.22% | 71 |
|
|
2022
Q1 | $1.05M | Buy |
18,854
+7,460
| +65% | +$414K | 0.17% | 76 |
|
|
2021
Q4 | $638K | Buy |
11,394
+3,094
| +37% | +$173K | 0.1% | 85 |
|
|
2021
Q3 | $398K | Buy |
8,300
+1,152
| +16% | +$55.2K | 0.08% | 82 |
|
|
2021
Q2 | $299K | Buy |
+7,148
| New | +$299K | 0.07% | 47 |
|